Chongqing Dilai Biotechnology

Chongqing Dilai Biotechnology is a Chinese biotechnology company dedicated to the field of in vitro diagnostics (IVD), with a primary focus on molecular diagnostic technologies. Founded in 2016 and headquartered in Chongqing, the company develops, manufactures, and markets a comprehensive range of products including nucleic acid extraction reagents, automated extraction systems, and real-time PCR detection kits. Their diagnostic portfolio addresses critical health areas such as infectious diseases, including HPV, HBV, and HCV, as well as oncology and genetic testing. Dilai Biotechnology operates within a GMP-compliant infrastructure and emphasizes the integration of automated platforms with high-sensitivity reagents to improve clinical workflow efficiency. The company aims to provide accessible and precise molecular testing solutions for hospitals and diagnostic centers globally.